Skip to contentI
Innoviva, Inc.
I
INVAInnoviva, Inc. Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$114.61M$114.61Mderived+24.8% vs Q4 2024 Net Income$164.15M$164.15Mderived+707.4% vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Innoviva, Inc. · CIK 1080014 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$75,667,000−3.2% Operating Incomederived$38,988,000−9.6% Operating Cash Flowderived$54,513,000−8.0% Free Cash Flowderived$54,503,000−8.0% Margins · derivedGross margin66.0%−19.1 pt vs Q4 2024
Operating margin34.0%−13.0 pt vs Q4 2024
Net margin143.2%+121.1 pt vs Q4 2024
ended Dec 31, 2025 · filed Feb 25, 2026 · 56 d after period end